Timothy C. Dec - Mar 14, 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Signature
/s/ Timothy C. Dec
Stock symbol
SUPN
Transactions as of
Mar 14, 2023
Transactions value $
-$30,495
Form type
4
Date filed
4/10/2023, 05:00 PM
Previous filing
Feb 27, 2023
Next filing
May 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $0 +1.5K +111.86% $0.00 2.84K Mar 14, 2023 Direct F1
transaction SUPN Common Stock Tax liability -$30.5K -789 -27.77% $38.65 2.05K Mar 14, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Options Exercise $0 -1.5K -100% $0.00* 0 Mar 14, 2023 Common Stock 1.5K $0.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on May 3, 2022.
F2 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting.
F3 On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period.